| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |